The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Bio Med Sciences sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Bio Med Sciences Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Bio Med Sciences is a developer and marketer of medical products. The company offers wound care and scar management, skin firming and eye wrinkling treatment products. Its wound care products include temporary skin replacement dressings for laser resurfacing, dermabrasion wounds, second degree burns, and skin tears; precut face mask dressings; face mask kits; and multi-functional wound dressings. Bio Med’s scar management products comprise transparent silicon sheeting, silicon sheeting with fabric backing, precut shapes for scar management, silicone sheeting with foam backing, silicone elastomer sheeting, silicone thermoplastic splinting, low-temperature thermoplastic splinting, and silicone bonded textile. It also provides contract research and development services. The company sells its products through distributors to patients, consumers and clinical practices. Bio Med is headquartered in Allentown, Pennsylvania, the US.

The key metrics of Bio Med Sciences related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Bio Med Sciences is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Bio Med Sciences.

For a detailed understanding of the performance of Bio Med Sciences, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.